Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2022 | New findings on the utility of circulating biomarkers for liquid biopsy

Catherine Alix-Panabieres • 12 Apr 2022
AACR 2022
General

Catherine Alix-Panabieres, PhD, University Medical Center of Montpellier, Montpellier, France, summarises the recent updates on the utility of two circulating biomarkers; Dr Shannon Stott’s research on how to detect exosomes and their role in the metastatic cascade and Dr Valerie Taly’s sensitive method for detecting circulating tumor DNA (ctDNA) with digital PCR. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2022 in New Orleans, LA.

More from Catherine Alix-Panabieres

Challenges to implementing liquid biopsy in clinical practice
1:49
Challenges to implementing liquid biopsy in clinical practice
Catherine Alix-Panabieres • 12 Apr 2022
Liquid biopsy: an essential complementary tool to the tissue biopsy
1:45
Liquid biopsy: an essential complementary tool to the tissue biopsy
Catherine Alix-Panabieres • 12 Apr 2022
The importance of studying circulating tumor cell lines
1:19
The importance of studying circulating tumor cell lines
Catherine Alix-Panabieres • 12 Apr 2022
Clinical relevance of lipid biopsy and circulating tumor cells for precision medicine
1:07
Clinical relevance of lipid biopsy and circulating tumor cells for precision medicine
Catherine Alix-Panabieres • 12 Apr 2022

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals